HI-Bio - Ownership and Business Overview

Life ScienceCompany

HI-Bio Ownership

Who owns HI-Bio?

HI-Bio is owned by Biogen. It was acquired on May 22, 2024.

HI-Bio Business Overview

Where is HI-Bio headquartered?

HI-Bio is headquartered in South San Francisco, California.

What sector is HI-Bio in?

HI-Bio is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 165 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 151 by strategics.

HI-Bio

Human Immunology Biosciences

6000 Shoreline Court, Suite 304,
South San Francisco, California 94080
United States,
www.hibio.com

HI-Bio is a clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases (IMDs). The company’s felzartamab is a CD38-targeted antibody shown in clinical studies to deplete CD38+ cells, including plasma and natural killer (NK) cells, which are implicated in a range of indications including antibody-mediated rejection (AMR), IgA nephropathy (IgAN), lupus nephritis (LN) and primary membranous nephropathy (PMN). HI-Bio is based in South San Francisco, California.


 Subscribe to unlock this and 206,813
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.